rs139492208
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_003334.4(UBA1):āc.2595A>Gā(p.Ala865Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000422 in 1,209,932 control chromosomes in the GnomAD database, including 4 homozygotes. There are 131 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0023 ( 2 hom., 71 hem., cov: 22)
Exomes š: 0.00023 ( 2 hom. 60 hem. )
Consequence
UBA1
NM_003334.4 synonymous
NM_003334.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.505
Genes affected
UBA1 (HGNC:12469): (ubiquitin like modifier activating enzyme 1) The protein encoded by this gene catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation. This gene complements an X-linked mouse temperature-sensitive defect in DNA synthesis, and thus may function in DNA repair. It is part of a gene cluster on chromosome Xp11.23. Alternatively spliced transcript variants that encode the same protein have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant X-47212812-A-G is Benign according to our data. Variant chrX-47212812-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 465034.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.505 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBA1 | NM_003334.4 | c.2595A>G | p.Ala865Ala | synonymous_variant | 22/26 | ENST00000335972.11 | NP_003325.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBA1 | ENST00000335972.11 | c.2595A>G | p.Ala865Ala | synonymous_variant | 22/26 | 1 | NM_003334.4 | ENSP00000338413.6 | ||
UBA1 | ENST00000377351.8 | c.2595A>G | p.Ala865Ala | synonymous_variant | 22/26 | 1 | ENSP00000366568.4 | |||
UBA1 | ENST00000377269.3 | c.939A>G | p.Ala313Ala | synonymous_variant | 6/10 | 2 | ENSP00000366481.3 |
Frequencies
GnomAD3 genomes AF: 0.00234 AC: 262AN: 111746Hom.: 2 Cov.: 22 AF XY: 0.00209 AC XY: 71AN XY: 33922
GnomAD3 genomes
AF:
AC:
262
AN:
111746
Hom.:
Cov.:
22
AF XY:
AC XY:
71
AN XY:
33922
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000744 AC: 136AN: 182805Hom.: 1 AF XY: 0.000476 AC XY: 32AN XY: 67287
GnomAD3 exomes
AF:
AC:
136
AN:
182805
Hom.:
AF XY:
AC XY:
32
AN XY:
67287
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000227 AC: 249AN: 1098132Hom.: 2 Cov.: 31 AF XY: 0.000165 AC XY: 60AN XY: 363490
GnomAD4 exome
AF:
AC:
249
AN:
1098132
Hom.:
Cov.:
31
AF XY:
AC XY:
60
AN XY:
363490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00233 AC: 261AN: 111800Hom.: 2 Cov.: 22 AF XY: 0.00209 AC XY: 71AN XY: 33986
GnomAD4 genome
AF:
AC:
261
AN:
111800
Hom.:
Cov.:
22
AF XY:
AC XY:
71
AN XY:
33986
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 02, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Infantile-onset X-linked spinal muscular atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
UBA1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at